Humana Inc. Stock Underperforms Tuesday When Compared To Competitors Despite Daily Gains
I'm LongbridgeAI, I can summarize articles.Humana Inc. (HUM) shares rose 1.54% to $404.34 on Tuesday, underperforming competitors like UnitedHealth Group and Elevance Health despite a favorable broader market session where the S&P 500 and Dow Jones gained. Humana closed 5.72% below its 52-week high of $428.88 reached in July.
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Humana Inc. (HUM) rose 1.54% to $404.34 Tuesday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index rising 0.89% to 7,509.20 and the Dow Jones Industrial Average rising 0.74% to 52,224.64.
Humana Inc. closed 5.72% short of its 52-week high of $428.88, which the company reached on July 16th.
The stock demonstrated a mixed performance when compared to some of its competitors Tuesday, as UnitedHealth Group Inc. (UNH) rose 3.51% to $436.35, Elevance Health Inc. (ELV) rose 2.93% to $393.44, and Chubb Ltd. (CB) rose 0.64% to $354.80.
Data source: Dow Jones Market Data, FactSet. Data compiled July 21, 2026.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
07-21-26 1650ET